Mereo BioPharma (MREO) Interest Coverage Ratio Growth (1y) (2024 - 2026)
Mereo BioPharma (MREO) Interest Coverage Ratio Growth (1y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,071.81 Bn | - | -60.44% |
| 2 | Nanobiotix | 1,925.70 Bn | 1,925.64 Bn | - | - |
| 3 | Akari Therapeutics | 1,062.88 Bn | 1,062.88 Bn | - | -347.04% |
| 4 | BeOne Medicines | 469.09 Bn | 464.29 Bn | 1.35 Bn | 787.12% |
| 5 | Vertex Pharmaceuticals | 123.09 Bn | 115.84 Bn | 2.59 Bn | 53.59% |
| 6 | Regeneron Pharmaceuticals | 70.32 Bn | 61.57 Bn | 3.31 Bn | -32.04% |
| 7 | Belite Bio | 63.36 Bn | 63.36 Bn | - | - |
| 8 | Argenx Se | 55.90 Bn | 50.71 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.69 Bn | 34.68 Bn | 959.66 Mn | 1,378.45% |
| 10 | Mereo BioPharma | 231.56 Mn | 231.56 Mn | - | 27.06% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.06% |
| Dec 31, 2025 | 64.18% |
| Sep 30, 2025 | -427.14% |
| Jun 30, 2025 | -54.63% |
| Mar 31, 2025 | -82.69% |
| Dec 31, 2024 | -434.87% |
| Sep 30, 2024 | 96.97% |
| Jun 30, 2024 | 14.32% |
| Mar 31, 2024 | -123.91% |